Role of mesenchymal stem cells in modulating cytokine networks and immune checkpoints in gastric cancer therapy
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2025-10 · 1880 (5) · 189433
DOI: 10.1016/j.bbcan.2025.189433 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2025-10. Verfasst von Zakari Shaibu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, China; School of Medicine, Jiangsu Un…. Hauptthemen laut MEDLINE: Stomach Neoplasms, Mesenchymal Stem Cells, Immune Checkpoint Inhibitors, Cytokines. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 189 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Gastric cancer (GC) remains a leading cause of cancer-related mortality worldwide, driven by a complex tumor microenvironment (TME) that promotes disease progression and therapeutic resistance. This review explores the pivotal roles of mesenchymal stem cells (MSCs), cytokines, and immune checkpoint inhibitors (ICIs) in shaping the immunosuppressive GC TME, with emphasis on their interaction and implications for immunotherapy. MSCs secrete cytokines such as IL-6, TGF-β, and IL-10, fostering an immunosuppressive milieu that enables tumor growth, immune evasion, and resistance to ICIs. We synthesize current knowledge on how MSC-derived cytokines regulate immune checkpoint expression, suppress anti-tumor immunity, and contribute to TME heterogeneity. Additionally, we discuss therapeutic strategies targeting MSC-cytokine-immune checkpoint interactions to enhance ICI efficacy and improve clinical outcomes. Emerging approaches including MSC reprogramming, exosome-based therapies, and multi-omics technologies are highlighted as promising avenues to decipher TME complexity and develop personalized immunotherapies. By elucidating mechanisms of MSC-mediated immune modulation in GC, this review aims to inspire novel strategies to overcome therapeutic resistance in this challenging disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastrointestinal Surgery, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, China; School of Medicine, Jiangsu University, Zhenjiang, Jiangsu, China.
- School of Medicine, Jiangsu University, Zhenjiang, Jiangsu, China; Department of Radiation Oncology, Institute of Oncology, Affiliated Hospital, Jiangsu University, Zhenjiang, Jiangsu Province, China.
- Department of Gastrointestinal Surgery, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, China. Electronic address: Chenzhi-hong@163.com.
- School of Medicine, Jiangsu University, Zhenjiang, Jiangsu, China. Electronic address: zhuwei@ujs.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Shaibu, Z., Danbala, I. A., Chen, Z., & Zhu, W. (2025). Role of mesenchymal stem cells in modulating cytokine networks and immune checkpoints in gastric cancer therapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1880(5), 189433. https://doi.org/10.1016/j.bbcan.2025.189433
Vancouver
Shaibu Z, Danbala IA, Chen Z, Zhu W. Role of mesenchymal stem cells in modulating cytokine networks and immune checkpoints in gastric cancer therapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2025;1880(5):189433. doi:10.1016/j.bbcan.2025.189433
BibTeX
@article{Shaibu2025,
author = {Shaibu, Zakari and Danbala, Isah Adamu and Chen, Zhihong and Zhu, Wei},
title = {Role of mesenchymal stem cells in modulating cytokine networks and immune checkpoints in gastric cancer therapy},
journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
year = {2025},
volume = {1880},
number = {5},
pages = {189433},
doi = {10.1016/j.bbcan.2025.189433}
}
EUVIMED